Metabolic & Incretin · Research deep dive
Survodutide: the cited literature
Every study referenced in the Survodutide monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Survodutide is studied at 600 mcg – 6 mg per administration, typically once weekly. The reference walkthrough below maps each citation to what it actually showed.
References covered
Survodutide in adults with overweight or obesity
N. Engl. J. Med., 2024
A phase 2 trial of survodutide in MASH
N. Engl. J. Med., 2024
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Survodutide.